Credit: Albert Einstein College of Medicine website
Targeting Leukemia: Deactivating AML's Key Protein
Ulrich Steidl, M.D., Ph.D., studies the molecular pathways that lead to the development of leukemia. He recently identified a key protein responsible for causing acute myeloid leukemia, a particularly lethal and poorly treated form of cancer. He is now developing drugs that target and inactivate this protein, an entirely new approach to leukemia treatment. Dr. Steidl is assistant professor of cell biology and of medicine (oncology) and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research.
Ulrich G. Steidl, M.D., Ph.D.
- Professor, Department of Cell Biology
- Professor, Department of Medicine (Oncology)
- The Diane and Arthur B. Belfer Faculty Scholar in Cancer Research
- Leader, Stem Cells, Differentiation and Cancer Program, Albert Einstein Cancer Center
- Director, Stem Cell Isolation & Xenotransplantation Facility, Ruth L. and David S. Gottesman Institute for Stem Cell Research & Regenerative Medicine